DEA Under Scrutiny Amid Allegations of Cannabis Contamination Failures and Research Obstacles

A recent report has leveled significant allegations against the Drug Enforcement Administration (DEA), particularly targeting Deputy Administrator Thomas Prevoznik. The report claims the agency has allegedly failed in its duty to prevent contaminated cannabis products from entering state-regulated markets across the United States, leading to concerns that consumers are being exposed to potentially harmful substances….

Read More

Contaminated Cannabis Fears Rise Amid DEA Inaction, Research Delays Fuel Criticism

A recent report raises serious questions about the effectiveness of the U.S. Drug Enforcement Administration’s (DEA) approach to cannabis, alleging failures that jeopardize public safety in state-regulated markets while simultaneously hindering legitimate pharmaceutical research. The report, attributed to ACCESS Newswire, specifically highlights concerns surrounding the actions, or lack thereof, attributed to DEA Deputy Administrator Thomas…

Read More